All Posts
Next Friday’s big number for inflation, interest rates, and the Fed
At 8:30 a.m. on Friday, December 6, investors will see the U.S. jobs report for November. Economists expect that the economy added 200,000 jobs in the month and that for the unemployment rate will hold steady at 4.2%.
More evidence that the inflation rate is stuck
Yesterday, Wednesday, November 27, the report from the Bureau of Economic Analysis showed that the Personal Consumption Expenditures index, the Federal Reserve’s preferred inflation measure, had continued the stall that began in May.
Today I made Verizon Pick #6 in my Special Report: “3 Strategies and 10 Picks for Juicy Returns in a Yield Drought”
Today I made Verizon the sixth pick in my Special Report “3 Strategies and 1O Picks for a Yield Drought.” Here’s what I wrote.
25% tariffs for Mexico, China, and Canada: This won’t be the last time Trump talks tariffs
Yesterday in social media posts President-elect Donald Trump said that he would impose tariffs on his first day back in office, targeting the United States’ three largest trading partners, of 25% on all goods from Canada and Mexico until drugs and migrants stopped coming over the borders, and an additional 10% tariff on all products from China, saying that the country was shipping illegal drugs to the United States. (The Biden Administration had already imposed its own higher tariffs on China and, in additional, it had kept tariffs on China from the first Trump Administration in effect.)
Biden proposes/Trump disposes: Will GLP-1 diabetes/obesity drugs become free under Medicare and Medicaid?
The Biden administration has proposed making GLP-1 weight loss drugs free for low-income people and retirees who qualify as obese. Expensive drugs such as Ozempic, Wegovy and Zepbound, which cost $1,000 a month, would be covered for the 40% of the U.S. population who qualify as obese. Currently, the federal plans only cover the drugs when patients have other conditions caused by obesity, such as diabetes, heart disease. The leading drugs are made by Eli Lilly (LLY) and Novo Nordisk (NVO). Shares of Eli Lilly were up 4.55% today while Novo Nordisk rose 1.50%. The incoming Trump Administration will have to decide whether to move ahead with the plan. You can either think of this as a smart piece of health care policy or an effort to jam up an incoming administration that already faces challenges in devising coherent policy on healthcare. I go with the “jam ‘em up” theory myself.
Today I made Copa my 5th pick in my Special Report “10 picks for a Yield Draught”
Today I added Copa Holdings (CPA), an airline stock paying 6.9% to my Special Report. Here’s what I wrote
Today I added my first picks for losers after Trump’s election victory
These picks for Trump election losers shouldn’t come as a surprise: The President-elect has made it clear that he hates wind power. Here’s what I wrote in my update to my Special Report: “11 Trump election winners and 5 Trump/Harris losers.”
Saturday Night Quarterback says, For the week ahead expect…
I expect more temporizing this week on when to sell a market that everyone agrees is too expensive. It’s especially worthwhile checking on potential tax loss sells as we come out of a great 2024 and head into a much less predictable 2025.
I just added this to my Special Report: “3 Strategies and 10 Picks for Juicy Returns in a Yield Drought”:Why the 3-month Treasury bill is a great investment now
Let’s start with the 4.54% yield. And then note that, if you hold a bill to maturity, it is essentially risk free. Compare that combination to gold which has a comparable degree of risk but pays a yield of 0%. Or to a 3-month CD where the average U.S. yield is 1.52% or to a 6-month CD where the average U.S. yield is 1.68%.
Higher mortgage rates for longer?
Three days after the U.S. election, Redfin, the technology-driven real estate brokerage that does business in 100 markets, raised its projection for the average mortgage rate in 2025 to 6.8%. That’s roughly where the current average 30-year fixed mortgage rate stands now. Other real estate analysts, including Moody Analytics and Capital Economics, expect rates near 7% next year. This is bad news for two reasons.
Palo Alto Networks beats on earnings, but it’s not enough
Shares ofPalo Alto Networks (PANW) fell 5.32% in after-hours trading today, November 20. The company reported earnings for its first fiscal quarter after the market close. Non-GAAP earnings per share of $1.56 beat analyst estimates by $0.08. Revenue of $2.14 billion, an increase of 13.8% year-over-year, beat by $20 million. But it wasn’t enough for a stock that trades at 54 times trailing 12-month earnings per share.
Dr. Oz appointment news drives up Medicare Advantage stocks today
Health insurers traded higher today, November 20, after President-elect Donald Trump picked TV personality Dr. Mehmet Oz to head the U.S. Centers for Medicare and Medicaid Services, the agency responsible for overseeing healthcare coverage for millions of Americans.
Special Report: “3 Strategies and 10 Picks for Juicy Returns in a Yield Drought”–first 6 picks
If you’re an investor looking for income, you’re facing what I’d call a Yield Drought. And this is no temporary dry spell. Things on the income investing front look they’ll get worse before they get better. Unless a financial crisis intervenes in 2025 to make everything else much worse and the yield story much better. Because, you see, there are two parts to the current Yield Drought.
Please watch my YouTube video: Quick Pick Goldman Sachs
Today’s Quick Pick is Goldman Sachs (GS). This is not a cheap stock. Goldman has had a good run in 2024 and is up 55% year to date. But this is the stock to use play the financial deregulation policies of the Trump administration. We’re moving from Biden’s administration that had a relatively high degree of scrutiny in merger and acquisition deals to an administration that will come close to approving any deal Wall Street proposes. The deal pipeline is full. Companies that were waiting on the election results to move deals forward will start the process as soon as the new President is inaugurated. Running an M&A deal is incredibly lucrative for an investment bank. Goldman Sachs is a big player in this market and will benefit from doing M&As and LBOs. This pick is how I’ll be playing the Trump financial deregulation and I’ll be adding it to my Jubak Picks portfolio tomorrow.
Gold is up today on Ukraine worries, but the trend points up for all of 2025
Gold will rally to a record next year on central-bank buying and U.S. interest rate cuts, according to Goldman Sachs. The investment bank listed the metal among top commodity trades for 2025. “Go for gold,” analysts said in a note, reiterating a target of $3,000 an ounce by December 2025.
